Citation Impact
Citing Papers
A useful canine model of ischemic myocardium with coronary retrograde flow diversion, and its application for the study of allopurinol on myocardial infarct size.
1991
The relationship between oxygen radical generation and impairment of myocardial energy metabolism following post-ischemic reperfusion,
1991
Role of Oxidative-Nitrosative Stress and Downstream Pathways in Various Forms of Cardiomyopathy and Heart Failure
2005
Short-Term Effects of Nose-Only Cigarette Smoke Exposure on Glutathione Redox Homeostasis, Cytochrome P450 1A1/2 and Respiratory Enzyme Activities in Mice Tissues
2013 Standout
The Clinical Sequelae of Intravascular Hemolysis and Extracellular Plasma Hemoglobin
2005 Standout
Improved survival in intestinal ischemia by allopurinol not related to xanthine-oxidase inhibition
1990
Iron‐sulphur cluster nitrosyls, a novel class of nitric oxide generator: mechanism of vasodilator action on rat isolated tail artery
1992
Oxypurinol administration fails to prevent hypoxic–ischemic brain injury in neonatal rats
2003
Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications
2003
Effect of Allopurinol Pretreatment on Free Radical Generation after Primary Coronary Angioplasty for Acute Myocardial Infarction
2003
The 1991 Ulf von Euler Lecture:Thel ‐arginine: nitric oxide pathway
1992
Tissue Destruction by Neutrophils
1989 Standout
Behaviour of energy metabolites and effect of allopurinol in the “stunned” isovolumic rat heart
1990
Oxidative Stress And Potassium Channel Function
2002
Allopurinol enhanced adenine nucleotide repletion after myocardial ischemia in the isolated rat heart.
1988
Endothelial protective effects of preconditioning
2002
Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery
2002 Standout
Changes in xanthine oxidase in ischemic rat brain
1989
Myocardial ischemia-reperfusion injury: a neglected therapeutic target
2013 Standout
Monoamine oxidases (MAO) in the pathogenesis of heart failure and ischemia/reperfusion injury
2010
Myocardial Protection with Blood Cardioplegia in Ischemically Injured Hearts: Reduction of Reoxygenation Injury with Allopurinol
1988
Free Radicals and Their Involvement During Long-Term Myocardial Ischemia and Reperfusion
1990
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
ROS Function in Redox Signaling and Oxidative Stress
2014 Standout
Oxygen‐derived free radicals and postischemic myocardial reperfusion: therapeutic implications
1990
Involvement of free radicals in cerebral vascular reperfusion injury evaluated in a transient focal cerebral ischemia model of rat
1999
A randomized controlled trial of allopurinol in coronary bypass surgery
1991
Xanthine oxidase inhibition attenuates ischemic-reperfusion lung injury
1988
Regulation of β-Adrenergic Receptor Signaling by S-Nitrosylation of G-Protein-Coupled Receptor Kinase 2
2007 StandoutNobel
Peroxynitrite formation from human myocardium after ischemia-reperfusion during open heart operation
2001
Effects of inhaled nitric oxide on regional blood flow are consistent with intravascular nitric oxidedelivery
2001
Role of Oxidative Modifications in Atherosclerosis
2004 Standout
Substrate Control of Free Radical Generation from Xanthine Oxidase in the Postischemic Heart
1995
Allopurinol and amlodipine improve coronary vasodilatation after myocardial ischaemia and reperfusion in anaesthetized dogs
1993
Central nervous systems trauma and stroke
1989
Species variation in the coronary collateral circulation during regional myocardial ischaemia: a critical determinant of the rate of evolution and extent of myocardial infarction
1987
Interaction of Cardiovascular Risk Factors with Myocardial Ischemia/Reperfusion Injury, Preconditioning, and Postconditioning
2007
Regional coronary haemodynamic effects of two inhibitors of nitric oxide synthesis in anaesthetized, open‐chest dogs
1991
Biochemical Mechanisms for Oxygen Free Radical Formation During Exercise
1990
The L-Arginine-Nitric Oxide Pathway
1993 Standout
Leukocyte-depleted terminal blood cardioplegia provides superior myocardial protective effects in association with myocardium-derived nitric oxide and peroxynitrite production for patients undergoing prolonged aortic crossclamping for more than 120 minutes
2003
Nitric oxide's reactions with hemoglobin: a view through the SNO-storm
2003
Sickle-cell disease
2010 Standout
Recent advances in SPME techniques in biomedical analysis
2010
Free radicals and antioxidants in normal physiological functions and human disease
2006 Standout
Poly(ethylene glycol) in Drug Delivery: Pros and Cons as Well as Potential Alternatives
2010 Standout
Imaging Dynamic Redox Changes in Mammalian Cells with Green Fluorescent Protein Indicators
2004 StandoutNobel
l -Arginine for the prevention and treatment of coronary artery disease
2001
Cellular distribution, metabolism and regulation of the xanthine oxidoreductase enzyme system
2000
Interaction Between Allopurinol and Copper: Possible Role in Myocardial Protection
1993
Myocardial Reperfusion Injury
2007 Standout
Therapeutic Effects of Xanthine Oxidase Inhibitors: Renaissance Half a Century after the Discovery of Allopurinol
2006 Standout
Nitric oxide activity in the human coronary circulation. Impact of risk factors for coronary atherosclerosis.
1995
The role of oxidants and free radicals in reperfusion injury
2006
Allopurinol-enhanced myocardial protection does not involve xanthine oxidase inhibition or purine salvage
1992
Polyethylene glycol–superoxide dismutase, a conjugate in search of exploitation
2002
Excitatory Amino Acids as a Final Common Pathway for Neurologic Disorders
1994 Standout
Small vessel phenomena in the coronary microcirculation: Phasic intramyocardial perfusion and coronary microvascular dynamics
1988
Protection afforded by allopurinol in the first 24 hours of coronary occlusion is diminished after 48 hours
1988
EGLN1 Inhibition and Rerouting of α-Ketoglutarate Suffice for Remote Ischemic Protection
2016 StandoutNobel
Biomarkers in Heart Failure
2008 Standout
The xanthine oxidase inhibitor oxypurinol does not limit infarct size in a canine model of 40 minutes of ischemia with reperfusion
1988
Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes
1991 Standout
Possible involvement of l-arginine-nitric oxide pathway in modulating regional blood flow to brown adipose tissue of rats
1994
Effect of azapropazone and allopurinol on myocardial infarct size in rats
1987
Influence of allopurinol on cardiac complications in open heart operations
1991
The cellular and molecular origin of reactive oxygen species generation during myocardial ischemia and reperfusion
2011
Biochemistry of Nitric Oxide and Its Redox-Activated Forms
1992 StandoutScience
Effects of allopurinol pretreatment on myocardial ultrastructure and arrhythmias following coronary artery occlusion and reperfusion
1986
Myocardial reperfusion: a double-edged sword?
1985
Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients
1994 Standout
Role of Endothelial Dysfunction in Atherosclerosis
2004 Standout
Marked reduction of free radical generation and contractile dysfunction by antioxidant therapy begun at the time of reperfusion. Evidence that myocardial "stunning" is a manifestation of reperfusion injury.
1989
PTEN Activity Is Modulated During Ischemia and Reperfusion
2005 StandoutNobel
The importance of free radicals and catalytic metal ions in human diseases
1985
O2-regulated gene expression: transcriptional control of cardiorespiratory physiology by HIF-1
2004 StandoutNobel
Konzentration Thiobarbitursäure-reaktiver Substanzen (TBARS) im Serum nach Myokardinfarkt
1986
Ascorbate is an outstanding antioxidant in human blood plasma.
1989 Standout
Reperfusion-induced arrhythmias and oxygen-derived free radicals. Studies with "anti-free radical" interventions and a free radical-generating system in the isolated perfused rat heart.
1986
Loss of endothelium-dependent vasodilatation and nitric oxide release after myocardial protection with University of Wisconsin solution
1994 StandoutNobel
Prognostic Impact of Coronary Vasodilator Dysfunction on Adverse Long-Term Outcome of Coronary Heart Disease
2000 Standout
Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin.
1992
Validation of a Doppler guide wire for intravascular measurement of coronary artery flow velocity.
1992 Standout
Intravascular flow decreases erythrocyte consumption of nitric oxide
1999
Mitochondrial Reactive Oxygen Species (ROS) and ROS-Induced ROS Release
2014 Standout
Adaptive and Maladaptive Cardiorespiratory Responses to Continuous and Intermittent Hypoxia Mediated by Hypoxia-Inducible Factors 1 and 2
2012 StandoutNobel
Allopurinol Neurocardiac Protection Trial in Infants Undergoing Heart Surgery Using Deep Hypothermic Circulatory Arrest
2001
Brown Adipose Tissue: Function and Physiological Significance
2004 Standout
Uric Acid and Survival in Chronic Heart Failure
2003
Myocardial consequences of reperfusion
1987
Lack of cardioprotective efficacy of allopurinol in coronary artery surgery.
1994
Role of Nitric Oxide in the Regulation of the Mechanical Properties of Peripheral Conduit Arteries in Humans
1997
Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium.
1986 Standout
Hearts From Rodents Exposed to Intermittent Hypoxia or Erythropoietin Are Protected Against Ischemia-Reperfusion Injury
2003 StandoutNobel
Oxygen Radicals and Human Disease
1987 Standout
Chronic administration of allopurinol fails to exert any cardioprotective effect in rats submitted to permanent coronary artery ligation
1991
Reduction of reperfusion injury in the canine preparation by intracoronary adenosine: importance of the endothelium and the no-reflow phenomenon.
1987
Effects of supplementing hypothermic crystalloid cardioplegic solution with catalase, superoxide dismutase, allopurinol, or deferoxamine on functional recovery of globally ischemic and reperfused isolated hearts
1986
Measurement of superoxide-derived free radicals in the reperfused heart. Evidence for a free radical mechanism of reperfusion injury.
1988
Ischemic Cell Death in Brain Neurons
1999 Standout
Non-invasive measurement of endothelial function: effect on brachial artery dilatation of graded endothelial dependent and independent stimuli.
1997
Cloning and characterization of a functional human homolog of Escherichia coli endonuclease III
1997 StandoutNobel
Effects of allopurinol on myocardial ischemic injury induced by coronary artery ligation and reperfusion
1987
Effect of ischemia-reperfusion on xanthine oxidase activity in fetal rat brain capillaries
1999
Caged nitric oxide. Stable organic molecules from which nitric oxide can be photoreleased.
1994 StandoutNobel
The Mononuclear Molybdenum Enzymes
2014 Standout
Cardiac stress protein elevation 24 hours after brief ischemia or heat stress is associated with resistance to myocardial infarction.
1993 Standout
Xanthine oxidase inhibition does not limit canine infarct size.
1991
Novel Myofilament Ca 2+ -Sensitizing Property of Xanthine Oxidase Inhibitors
1998
Allopurinol and dimethylthiourea reduce brain infarction following middle cerebral artery occlusion in rats.
1989
Allopurinol improves myocardial reperfusion injury in a xanthine oxidase-free model.
1995
Allopurinol and oxypurinol are hydroxyl radical scavengers
1987
Hypoxia-inducible factor 1 is required for remote ischemic preconditioning of the heart
2013 StandoutNobel
Evidence that mitochondrial respiration is a source of potentially toxic oxygen free radicals in intact rabbit hearts subjected to ischemia and reflow.
1993
Free Radicals in the Physiological Control of Cell Function
2002 Standout
The protective action of allopurinol in an experimental model of haemorrhagic shock and reperfusion
1986
Reduction of the size of infarction by allopurinol in the ischemic-reperfused canine heart.
1986
Nitric Oxide Is Responsible for Flow-Dependent Dilatation of Human Peripheral Conduit Arteries In Vivo
1995 Standout
Neurodevelopmental Outcomes in Children With Congenital Heart Disease: Evaluation and Management
2012 Standout
Nifedipine
1995 Standout
Creatine and Creatinine Metabolism
2000 Standout
Oxypurinol limits myocardial stunning but does not reduce infarct size after reperfusion.
1987
Effect of nifedipine on enzymatically estimated infarct size in the early phase of acute myocardial infarction.
1988
Treatment of Periodontitis and Endothelial Function
2007 Standout
Hypoxia-inducible factor 1 transcriptional activity in endothelial cells is required for acute phase cardioprotection induced by ischemic preconditioning
2012 StandoutNobel
Allopurinol Improves Cardiac Dysfunction After Ischemia-Reperfusion via Reduction of Oxidative Stress in Isolated Perfused Rat Hearts
2003
The oxygen free radical system: A fundamental mechanism in the production of myocardial necrosis
1986
Molecular imprinting: perspectives and applications
2016 Standout
Endothelial Function and Dysfunction
2007 Standout
Works of David Chambers being referenced
Quantification of 31 volatile organic compounds in whole blood using solid-phase microextraction and gas chromatography–mass spectrometry☆
2006
Xanthine oxidase is not a source of free radicals in the ischemic rabbit heart
1987
Effects of inhibition of nitric oxide formation on basal vasomotion and endothelium-dependent responses of the coronary arteries in awake dogs.
1991
Xanthine oxidase as a source of free radical damage in myocardial ischemia
1985
Nitric oxide modulates epicardial coronary basal vasomotor tone in awake dogs
1990
Infarct size limitation by the xanthine oxidase inhibitor, allopurinol, in closed-chest dogs with small infarcts
1985
The role of vascular capacitance in the coronary arteries.
1984
Sustained limitation of myocardial necrosis 24 hours after coronary artery occlusion: Verapamil infusion in dogs with small myocardial infarcts
1983
Effects of flurbiprofen in altering the size of myocardial infarcts in dogs: Reduction or delay?
1983
The inability of isoproterenol or propranolol to alter the lateral dimensions of experimentally induced myocardial infarcts
1982
Ischemia-induced epicardial vasoconstriction. A potential mechanism for distant myocardial ischemia.
1990
Nifedipine limits infarct size for 24 hours in closed chest coronary embolized dogs
1985